These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 825249)

  • 1. [Antiheparin immunoglobulin in malignant lymphoma with hypertriglyceridemia, in the hamster].
    Beaumont JL; Beaumont V; Boisnier C; Szondy E; Vranckx R
    C R Acad Hebd Seances Acad Sci D; 1976 Nov; 283(11 D):1369-72. PubMed ID: 825249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperlipemia and tumors : post heparin lipase activity of the hamster bearing a malignant lymphoma].
    Beaumont V; Bérard M; Boisnier C; Beaumont JL
    C R Acad Hebd Seances Acad Sci D; 1975 Feb; 280(5):665-8. PubMed ID: 809163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A circulating inhibitor of post-heparin plasma lipolysis in the type IV-V hyperlipoproteinemia induced in Green lymphoma-bearing hamsters.
    Beaumont V; Berard M; Beaumont JL
    Adv Exp Med Biol; 1977; 82():262-4. PubMed ID: 200094
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertriglyceridemia and tumors. Production of stable cultures of Green's lymphoma].
    Bérard M; Antonucci M; Beaumont JL
    C R Seances Acad Sci III; 1981 Jan; 292(1):25-8. PubMed ID: 6786768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia and tumors: the hyperlipidemia of lymphoma-bearing hamsters.
    Beaumont V; Beaumont JL
    Biomedicine; 1974 Jan; 20(1):68-73. PubMed ID: 4841652
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of postheparin lipolytic activity in uremia and its relationship to hypertriglyceridemia.
    Boyer JL; Scheig RL
    Proc Soc Exp Biol Med; 1970 Jul; 134(3):603-5. PubMed ID: 5431345
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein lipase activity and hypertriglyceridemia in alloxan diabetic rabbits.
    O'Connor TP; Schnatz JD
    Metabolism; 1968 Sep; 17(9):838-44. PubMed ID: 5674129
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of lipoprotein lipase activity by a monoclonal immunoglobulin in autoimmune hyperlipidemia.
    Beaumont JL; Berard M; Antonucci M; Delplanque B; Vranckx R
    Atherosclerosis; 1977 Jan; 26(1):67-77. PubMed ID: 836349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein lipase and hepatic lipase activity in post-heparin plasma of patients with hypertriglyceridemia.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Adv Exp Med Biol; 1977; 82():149-51. PubMed ID: 200085
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of lipolytic enzymes in the development of hyperlipidemia induced by administration of heterologous albumin in rabbits].
    Serrano DS; Nikul'cheva NG; Soliternova IB
    Biull Eksp Biol Med; 1984 Jan; 97(1):42-5. PubMed ID: 6692022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.
    Breckenridge WC; Little JA; Steiner G; Chow A; Poapst M
    N Engl J Med; 1978 Jun; 298(23):1265-73. PubMed ID: 565877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism.
    Huttunen JK; Ehnholm C; Kekki M; Nikkilä EA
    Clin Sci Mol Med; 1976 Apr; 50(4):249-60. PubMed ID: 1261206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
    Ibels SL; Reardon MF; Nestel PJ
    J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An anti-heparin immunoglobulin in a hyperlipidemic serum. (A new variety of auto-antibody hyperlipidemia)].
    Beaumont JL; Lemort N
    C R Acad Hebd Seances Acad Sci D; 1970 Dec; 271(25):2452-4. PubMed ID: 4995522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and function of anti-lipoprotein lipase auto-antibodies in type V hyperchylomicronemia.
    Moret M; Pruneta-Deloche V; Sassolas A; Marcais C; Moulin P
    Atherosclerosis; 2010 Feb; 208(2):324-7. PubMed ID: 19695572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlipidemia in acute lymphoblastic leukemia.
    Blackett PR; Koren E; Blackstock R; Downs D; Wang CS
    Ann Clin Lab Sci; 1984; 14(2):123-9. PubMed ID: 6585175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective protamine sulphate inactivation of lipoprotein lipase and hepatic lipase in human post-heparin plasma: specific lipase levels in normals and in type I hyperlipoproteinaemia.
    Berger GM; Abraham PR
    Clin Chim Acta; 1977 Dec; 81(3):219-28. PubMed ID: 923094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertriglyceridemia associated with decreased post-heparin plasma hepatic triglyceride lipase activity in hypoxic rats.
    Muratsubaki H; Enomoto K; Ichijoh Y; Yamamoto Y
    Arch Physiol Biochem; 2003 Dec; 111(5):449-54. PubMed ID: 16026033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mechanism of exogenous hyperglyceridemia.
    Glueck CJ; Kaplan AP; Levy RI; Greten H; Gralnick H; Fredrickson DS
    Ann Intern Med; 1969 Dec; 71(6):1051-62. PubMed ID: 5361405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.